Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

639.53
Delayed Data
As of Jul 07
 +12.28 / +1.96%
Today’s Change
271.37
Today|||52-Week Range
653.63
+70.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$63.7B

Company Description

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Contact Information

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591-6707
P:(914) 847-7000
Investor Relations:
(914) 847-3482

Employees

Shareholders

Mutual fund holders54.29%
Individual stakeholders23.74%
Other institutional15.46%

Top Executives

There are no executives to display.